Skip to main content
MJFF Feed

Michael J. Fox Talks Nike Mag and Parkinson's Research with Rachael Ray

Michael J. Fox Talks Nike Mag and Parkinson's Research with Rachael Ray

This morning, Michael J. Fox sat down with longtime Foundation friend Rachael Ray to discuss The Michael J. Fox Foundation's progress toward a cure and how anyone -- whether you have a Parkinson's connection or not -- can get involved.

Michael walked on set donning the futuristic (and sleek!) 2016 Nike Mag and spoke about the ways in which Parkinson's research informs the field's larger understanding of the brain and helps science beyond the disease:

The research that's being done now is big stuff and it covers a lot of bases. The philosophy at the Foundation is to throw a lot of chum out there and get the big fish. And it's to the benefit of everybody.

In referencing his diagnosis at age 29, Michael discussed how the Foundation is leading the global effort to discover a Parkinson's biomarker in order to diagnose and track disease progression:

When I had my pinky twitch the first time, 60 percent of my dopamine-producing brain cells were already gone. If we can find that earlier, if we can find a biomarker -- a way to take blood or have a piece of skin and know that that means that you're going to have Parkinson's -- we can then treat it earlier, we can come up with all kinds of answers.

Watch Michael's full appearance on the "Rachael Ray Show" here.

There's still time to enter the Nike Draw! One day remains to enter the Draw for a chance to own a limited-edition pair of the self-lacing Nike Mag shoes. For only $10 a ticket (with no limit to the number of tickets purchased) you'll be entered to win a piece of pop culture history. And since 100 percent of proceeds go straight to the Foundation, you'll bring us one step closer to a cure in the process! Enter the Draw at nike.com/mag.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.